Inflammatory processes associated with chylous ascites: A case report
DOI:
https://doi.org/10.59093/27112330.149Keywords:
chylous ascites, hepatic cirrhosis, peritonitis, cytokines, lymphangiogenesis.Abstract
Chylous ascites is a rare form of ascites characterized by the accumulation of milky peritoneal fluid rich in triglycerides, with levels exceeding 200 mg/dL. Its origin is often related to obstruction rupture of lymphatic vessels, with malignancy being the most common cause, followed by liver cirrhosis. The latter is associated with chronic inflammatory processes mediated by cytokines and endothelial growth factors that promote lymphangiogenesis, initially a compensatory mechanism for lymphatic drainage. However, dysfunction of this mechanism can result in lymph leakage into the peritoneal cavity. This article reports the case of a patient with liver cirrhosis, on the transplant waiting list, presenting with long-standing ascites and a recent episode of spontaneous bacterial peritonitis, in whom chylous ascites was documented during hospitalization. The discussion addresses both mechanical factors (portal hypertension, increased lymphatic pressure) and molecular factors, including macrophage activation and the expression of lymphangiogenic genes induced by proinflammatory cytokines. The aim of this article is to present a case report of a rare clinical condition in the medical literature and, based on its analysis, to propose how inflammatory processes may contribute to the development of pathological lymphangiogenesis and lymphatic rupture. The article concludes that translational studies are needed to further elucidate these mechanisms.
Downloads
References
Lizaola B, Bonder A, Trivedi HD, Tapper EB, Cardenas A. Review article: the diagnostic approach and current management of chylous ascites. Aliment Pharmacol Ther 2017;46:816-24. Epub septiembre 11 de 2017. http://doi.org/10.1111/apt.14284
Satala CB, Bara T Jr, Jung I, Tudorache V, Gurzu S. Chylous ascites, unusual association with ductal pancreatic adenocarcinoma with plasmacytoid morphology: a case report and literature review. Surg J 2021;7:e158-62. http://doi.org/10.1055/s-0041-1728651.
Chen ZQ, Zeng SJ, Xu C. Management of chylous ascites after liver cirrhosis: a case report. World J Hepatol 2025;17:100797. http://doi.org/10.4254/wjh.v17.i1.100797.
Gidaagaya S, Hu J-T, Chen D-S, Yang S-S. Acute rhabdomyolysis and chylous ascites in a patient with cirrhosis and malignant hepatic tumor. J Formos Med Assoc 2014;113:137-138. http://doi.org/10.1016/j.jfma.2011.07.019.
Romero S, Martin C, Hernandez L, Verdu J, Trigo C, Perez-Mateo M, et al. Chylothorax in cirrhosis of the liver. Chest 1998;114:154-159. http://doi.org/10.1378/chest.114.1.154.
Kumar R, Anand U, Priyadarshi RN. Lymphatic dysfunction in advanced cirrhosis: Contextual perspective and clinical implications. World J Hepatol 2021;13:300-314. http://doi.org/10.4254/wjh.v13.i3.300.
Schwager S, Detmar M. Inflammation and lymphatic function. Front Immunol 2019;10:308. http://doi.org/10.3389/fimmu.2019.00308.
Nilsson M, Heymach JV. Vascular endothelial growth factor (VEGF) pathway. J Thorac Oncol 2006;1:768-770. https://www.jto.org/article/S1556-0864(15)30404-4/fulltext.
Díaz-Trastoy O, Sánchez-Sobrino P, Rodríguez-Cañete BL, Vázquez-Temprano N, Murcia-Murcia C, Rodeiro-Marta SE. Management of chylous ascites and review of literature. Nutr Clin Diet Hosp 2022;42(01). http://doi.org/10.12873/421diaz.
Airola C, Varca S, Del Gaudio A, Pizzolante F. The covert side of ascites in cirrhosis: Cellular and molecular aspects. Biomedicines 2025;13:680. http://doi.org/10.3390/biomedicines13030680.
Kim KE, Koh Y-J, Jeon B-H, Jang C, Han J, Kataru RP, et al. Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm. Am J Pathol. 2009;175(4):1733–45. Epub octubre de 2009. http://dx.doi.org/10.2353/ajpath.2009.090133
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The authors retain copyright and grant the Colombian Association of Hepatology a non-exclusive right to publish and disseminate their work.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hepatología’s authorship policy is based on the criteria established by the International Committee of Medical Journal Editors (ICMJE) to credit a person for their work while assigning them responsibility for its publication.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |















